Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carol Giltner Gallagher currently holds 17,500 shares of Millendo Therapeutics, Inc. (MLND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carol Giltner Gallagher has been a net seller of MLND stock. They have purchased $465.6K and sold $2.5M worth of shares.
Carol Giltner Gallagher's most recent insider trade was on Oct 8, 2026, when they sold 17,500 shares at $0.00 per share.
Carol Giltner Gallagher serves as Executive at Millendo Therapeutics, Inc. (MLND). They have executed 76 insider transactions totaling $2.9M over their tenure at the company.
Carol Giltner Gallagher holds the position of Executive at Millendo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Carol Giltner Gallagher has shown a selling trading pattern, with $465.6K in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carol Giltner Gallagher was on Nov 7, 2018, when they sold $777.6K worth of ATRA shares. This transaction involved 21,374 shares at $36.38 per share.
Carol Giltner Gallagher currently owns 17,500 shares of Millendo Therapeutics, Inc. (MLND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carol Giltner Gallagher's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carol Giltner Gallagher has 76 Form 4 filings on record as an insider at Millendo Therapeutics, Inc..
Set alerts for Carol Giltner Gallagher and 40,000+ other insiders.